nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—bipolar disorder	0.89	1	CbGaD
Fluocinonide—SERPINA6—blood plasma—bipolar disorder	0.00859	0.146	CbGeAlD
Fluocinonide—SMO—adrenal cortex—bipolar disorder	0.00792	0.135	CbGeAlD
Fluocinonide—NR3C1—urine—bipolar disorder	0.00721	0.123	CbGeAlD
Fluocinonide—SMO—thyroid gland—bipolar disorder	0.00551	0.0939	CbGeAlD
Fluocinonide—SMO—nervous system—bipolar disorder	0.00464	0.079	CbGeAlD
Fluocinonide—SMO—cerebellum—bipolar disorder	0.00436	0.0743	CbGeAlD
Fluocinonide—NR3C1—blood plasma—bipolar disorder	0.00376	0.0641	CbGeAlD
Fluocinonide—SMO—brain—bipolar disorder	0.00354	0.0604	CbGeAlD
Fluocinonide—SERPINA6—nervous system—bipolar disorder	0.00255	0.0435	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—bipolar disorder	0.0024	0.0409	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—ADM—bipolar disorder	0.00203	0.0494	CbGpPWpGaD
Fluocinonide—SERPINA6—brain—bipolar disorder	0.00195	0.0333	CbGeAlD
Fluocinonide—NR3C1—adrenal cortex—bipolar disorder	0.00191	0.0325	CbGeAlD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR1D1—bipolar disorder	0.0015	0.0365	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—DRD3—bipolar disorder	0.00147	0.036	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—DRD4—bipolar disorder	0.00143	0.0349	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—GSK3B—bipolar disorder	0.0014	0.0341	CbGpPWpGaD
Fluocinonide—NR3C1—thyroid gland—bipolar disorder	0.00133	0.0227	CbGeAlD
Fluocinonide—SMO—Hedgehog 'off' state—ADCY2—bipolar disorder	0.00127	0.031	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GSK3B—bipolar disorder	0.00125	0.0306	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—NR1D1—bipolar disorder	0.00116	0.0283	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—ADCY2—bipolar disorder	0.00113	0.0276	CbGpPWpGaD
Fluocinonide—NR3C1—nervous system—bipolar disorder	0.00112	0.0191	CbGeAlD
Fluocinonide—NR3C1—Circadian Clock—NR1D1—bipolar disorder	0.00109	0.0266	CbGpPWpGaD
Fluocinonide—NR3C1—cerebellum—bipolar disorder	0.00105	0.0179	CbGeAlD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—bipolar disorder	0.00101	0.0248	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—HTR2A—bipolar disorder	0.000934	0.0228	CbGpPWpGaD
Fluocinonide—NR3C1—brain—bipolar disorder	0.000855	0.0146	CbGeAlD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.000845	0.0206	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.000811	0.0198	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD5—bipolar disorder	0.000766	0.0187	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—CLOCK—bipolar disorder	0.000739	0.018	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—GSK3B—bipolar disorder	0.000709	0.0173	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000667	0.0163	CbGpPWpGaD
Fluocinonide—Difluprednate—NR3C1—bipolar disorder	0.000639	0.0602	CrCbGaD
Fluocinonide—SMO—Signaling by Hedgehog—GSK3B—bipolar disorder	0.000632	0.0154	CbGpPWpGaD
Fluocinonide—Clocortolone—NR3C1—bipolar disorder	0.00062	0.0583	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000611	0.0149	CbGpPWpGaD
Fluocinonide—Desonide—NR3C1—bipolar disorder	0.000587	0.0552	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—bipolar disorder	0.000587	0.0552	CrCbGaD
Fluocinonide—Desoximetasone—NR3C1—bipolar disorder	0.000572	0.0538	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—ADM—bipolar disorder	0.000554	0.0135	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—TSHB—bipolar disorder	0.00054	0.0132	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—TACR1—bipolar disorder	0.00054	0.0132	CbGpPWpGaD
Fluocinonide—Flurandrenolide—NR3C1—bipolar disorder	0.000501	0.0471	CrCbGaD
Fluocinonide—Flumethasone Pivalate—NR3C1—bipolar disorder	0.000492	0.0463	CrCbGaD
Fluocinonide—Halobetasol Propionate—NR3C1—bipolar disorder	0.000484	0.0456	CrCbGaD
Fluocinonide—Amcinonide—NR3C1—bipolar disorder	0.00045	0.0424	CrCbGaD
Fluocinonide—Budesonide—NR3C1—bipolar disorder	0.00045	0.0424	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—HTR1A—bipolar disorder	0.000447	0.0109	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—NR3C1—bipolar disorder	0.000442	0.0416	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—TAC1—bipolar disorder	0.00044	0.0107	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD1—bipolar disorder	0.000432	0.0105	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2C—bipolar disorder	0.000432	0.0105	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DGKH—bipolar disorder	0.00043	0.0105	CbGpPWpGaD
Fluocinonide—Mometasone—NR3C1—bipolar disorder	0.000428	0.0403	CrCbGaD
Fluocinonide—Rimexolone—NR3C1—bipolar disorder	0.000423	0.0399	CrCbGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—bipolar disorder	0.000422	0.0103	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TCF7L2—bipolar disorder	0.000418	0.0102	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—bipolar disorder	0.000418	0.0102	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD3—bipolar disorder	0.000418	0.0102	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD4—bipolar disorder	0.000406	0.0099	CbGpPWpGaD
Fluocinonide—Beclomethasone—NR3C1—bipolar disorder	0.000399	0.0376	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—DRD5—bipolar disorder	0.000393	0.00959	CbGpPWpGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—bipolar disorder	0.000388	0.0365	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—RGS4—bipolar disorder	0.000386	0.00941	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD2—bipolar disorder	0.000378	0.00922	CbGpPWpGaD
Fluocinonide—Flunisolide—NR3C1—bipolar disorder	0.000378	0.0356	CrCbGaD
Fluocinonide—Clobetasol propionate—NR3C1—bipolar disorder	0.000378	0.0356	CrCbGaD
Fluocinonide—Paramethasone—NR3C1—bipolar disorder	0.000373	0.0351	CrCbGaD
Fluocinonide—Ciclesonide—NR3C1—bipolar disorder	0.000367	0.0346	CrCbGaD
Fluocinonide—Fluorometholone—NR3C1—bipolar disorder	0.000364	0.0343	CrCbGaD
Fluocinonide—Methylprednisolone—NR3C1—bipolar disorder	0.000352	0.0331	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000343	0.00838	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—bipolar disorder	0.000335	0.00818	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000313	0.00763	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000313	0.00763	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TRPC3—bipolar disorder	0.000298	0.00727	CbGpPWpGaD
Fluocinonide—Triamcinolone—NR3C1—bipolar disorder	0.000297	0.0279	CrCbGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—bipolar disorder	0.000293	0.00714	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—GATA3—bipolar disorder	0.000289	0.00706	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADM—bipolar disorder	0.000284	0.00694	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PDE4B—bipolar disorder	0.000277	0.00676	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TACR1—bipolar disorder	0.000277	0.00676	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TSHB—bipolar disorder	0.000277	0.00676	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKR1C4—bipolar disorder	0.000276	0.00673	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—NR3C1—bipolar disorder	0.000265	0.025	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—bipolar disorder	0.000265	0.00646	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000259	0.00631	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000255	0.00622	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DGKH—bipolar disorder	0.000254	0.0062	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00025	0.0061	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00025	0.0061	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00025	0.0061	CbGpPWpGaD
Fluocinonide—Betamethasone—NR3C1—bipolar disorder	0.000243	0.0229	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000243	0.00593	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD5—bipolar disorder	0.000232	0.00567	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1A—bipolar disorder	0.000229	0.0056	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RGS4—bipolar disorder	0.000228	0.00556	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TAC1—bipolar disorder	0.000226	0.00551	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD1—bipolar disorder	0.000221	0.0054	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2C—bipolar disorder	0.000221	0.0054	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD3—bipolar disorder	0.000214	0.00523	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—POMC—bipolar disorder	0.000211	0.00516	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD4—bipolar disorder	0.000208	0.00508	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—bipolar disorder	0.000206	0.00504	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—bipolar disorder	0.000205	0.005	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR1D1—bipolar disorder	0.0002	0.00488	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADCY2—bipolar disorder	0.000196	0.00478	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD2—bipolar disorder	0.000194	0.00473	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000188	0.00459	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000181	0.00443	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRPC3—bipolar disorder	0.000176	0.0043	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADM—bipolar disorder	0.000168	0.0041	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TSHB—bipolar disorder	0.000164	0.00399	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDE4B—bipolar disorder	0.000164	0.00399	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TACR1—bipolar disorder	0.000164	0.00399	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000153	0.00374	CbGpPWpGaD
Fluocinonide—Dexamethasone—NR3C1—bipolar disorder	0.000141	0.0133	CrCbGaD
Fluocinonide—NR3C1—Adipogenesis—INS—bipolar disorder	0.000141	0.00344	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—bipolar disorder	0.000136	0.00331	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1A—bipolar disorder	0.000135	0.00331	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TAC1—bipolar disorder	0.000133	0.00326	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2C—bipolar disorder	0.000131	0.00319	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD1—bipolar disorder	0.000131	0.00319	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—bipolar disorder	0.000127	0.00311	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD3—bipolar disorder	0.000127	0.00309	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GSK3A—bipolar disorder	0.000126	0.00308	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD4—bipolar disorder	0.000123	0.003	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADCY2—bipolar disorder	0.000116	0.00283	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TCF7L2—bipolar disorder	0.000115	0.00282	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD2—bipolar disorder	0.000115	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—POMC—bipolar disorder	0.000108	0.00265	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK1—bipolar disorder	0.000104	0.00253	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—S100B—bipolar disorder	0.000101	0.00246	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NR1D1—bipolar disorder	9.63e-05	0.00235	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—bipolar disorder	9.09e-05	0.00222	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRG1—bipolar disorder	8.9e-05	0.00217	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—bipolar disorder	8.03e-05	0.00196	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GSK3B—bipolar disorder	6.46e-05	0.00158	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—POMC—bipolar disorder	6.41e-05	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INS—bipolar disorder	6.37e-05	0.00156	CbGpPWpGaD
